Literature DB >> 228945

A possibe alpha-adrenergic mechanism for drug (CRL 40028)-induced hyperactivity.

J Duteil, F A Rambert, J Pessonnier, R Gombert, E Assous.   

Abstract

CRL 40028 (benzhydryl sulfinyl acetohydroxamic acid)-induced stimulation in mice, measured as an increase in locomotor activity was studied following an intraperitoneal injection of drugs known to block alpha-adrenergic receptors. Phenoxybenzamine (20 mg/kg), prazosin (0.5-1 mg/kg) and yohimbine (2 mg/kg) prevented the development of CRL 40028-induced hyperactivity. These results suggest that stimulation of an alpha-adrenergic postsynaptic receptor is of importance for the stimulant effect of CRL 40028.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228945     DOI: 10.1016/0014-2999(79)90033-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

2.  Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration.

Authors:  J F Hermant; F A Rambert; J Duteil
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse.

Authors:  R Chermat; L Doaré; F Lachapelle; P Simon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

4.  Effects of single and repeated treatment with antidepressants on apomorphine-induced yawning in the rat: the implication of alpha-1 adrenergic mechanisms in the D-2 receptor function.

Authors:  A Delini-Stula; C Hunn
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Modafinil for people with schizophrenia or related disorders.

Authors:  Javier Ortiz-Orendain; Sergio A Covarrubias-Castillo; Alan Omar Vazquez-Alvarez; Santiago Castiello-de Obeso; Gustavo E Arias Quiñones; Maya Seegers; Luis Enrique Colunga-Lozano
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.